372(top 1%)
papers
15.8K(top 1%)
citations
56(top 1%)
h-index
117(top 1%)
g-index
396
all documents
17.0K
doc citations
1.9K
citing journals

Top Articles

#TitleJournalYearCitations
1EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016European Urology20171,594
2European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 UpdateEuropean Urology2019936
3European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 UpdateEuropean Urology2015804
4European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 UpdateEuropean Urology2018627
5Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment StrategyEuropean Urology2009584
6European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)European Urology2022559
7European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 UpdateEuropean Urology2021532
8Detection of Early Bladder Cancer by 5-Aminolevulinic Acid Induced Porphyrin FluorescenceJournal of Urology1996409
9High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experienceUrology2004321
10Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responsesin vitroInternational Journal of Cancer2006276
11Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)World Journal of Urology2017260
12Clinically Relevant Reduction in Risk of Recurrence of Superficial Bladder Cancer Using 5-Aminolevulinic Acid-Induced Fluorescence Diagnosis: 8-Year Results of Prospective Randomized StudyUrology2007252
13Shock Wave Technology and Application: An UpdateEuropean Urology2011251
14Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trialNature Medicine2020245
15Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines PanelEuropean Urology2016215
16Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic ReviewEuropean Urology2017205
17European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines PanelEuropean Urology2021198
18First Analysis of the Long-Term Results with Transrectal HIFU in Patients with Localised Prostate CancerEuropean Urology2008197
19Early Versus Deferred Cystectomy for Initial High-Risk pT1G3 Urothelial Carcinoma of the Bladder: Do Risk Factors Define Feasibility of Bladder-Sparing Approach?European Urology2008179
20Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder CancerEuropean Urology2011176
21Prediction of 90-day Mortality After Radical Cystectomy for Bladder Cancer in a Prospective European Multicenter CohortEuropean Urology2014156
22Prediction of Progression of Non–Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective StudyEuropean Urology2008148
23The Tumor Immune Microenvironment Drives a Prognostic Relevance That Correlates with Bladder Cancer SubtypesCancer Immunology Research2019148
24ICUD-EAU International Consultation on Bladder Cancer 2012: Non–Muscle-Invasive Urothelial Carcinoma of the BladderEuropean Urology2013137
25Prediction of Intravesical Recurrence After Radical Nephroureterectomy: Development of a Clinical Decision-making ToolEuropean Urology2014134
26EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†European Urology2020132
27Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinomaOncogene2007127
28Sleep Apnea is an Independent Correlate of Erectile and Sexual DysfunctionJournal of Sexual Medicine2009120
29Eight Years' Experience With High-Intensity Focused Ultrasonography for Treatment of Localized Prostate CancerUrology2008114
30Grading of Urothelial Carcinoma and The New “World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016”European Urology Focus2019112
31Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic ReviewEuropean Urology Focus2019103
32EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines CommitteesAnnals of Oncology201996
33Topographical Anatomy of Periprostatic and Capsular Nerves: Quantification and Computerised PlanimetryEuropean Urology200895
34Photodynamic Diagnostics and Noninvasive Bladder Cancer: Is It Cost-Effective in Long-Term Application? A Germany-Based Cost AnalysisEuropean Urology200790
35Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancerWorld Journal of Urology200686
36The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancerBJU International201186
37FGFR3 Mutations and a Normal CK20 Staining Pattern Define Low-Grade Noninvasive Urothelial Bladder TumoursEuropean Urology200784
38Chromosome 9 deletions are more frequent thanFGFR3 mutations in flat urothelial hyperplasias of the bladderInternational Journal of Cancer200683
39Female Gender Is Associated With a Worse Survival After Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Competing Risk AnalysisUrology201482
40High Frequency of FGFR3 Mutations in Adenoid Seborrheic KeratosesJournal of Investigative Dermatology200679
41Combination of CK20 and Ki-67 Immunostaining Analysis Predicts Recurrence, Progression, and Cancer-Specific Survival in pT1 Urothelial Bladder CancerEuropean Urology201479
42Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-–small cell lung cancerHuman Pathology200876
43Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumabEuropean Journal of Cancer201975
44Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladderBJU International201274
45Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non–muscle-invasive Bladder CancerEuropean Urology Focus201974
46Reduction in incidence of lymphocele following extraperitoneal radical prostatectomy and pelvic lymph node dissection by bilateral peritoneal fenestrationWorld Journal of Urology200873
47Evolution and Outcomes of 3 MHz High Intensity Focused Ultrasound Therapy for Localized Prostate Cancer During 15 YearsJournal of Urology201369
48A Comparison of Outcomes for Interfascial and Intrafascial Nerve-sparing Radical ProstatectomyUrology201068
49PSA Nadir Is a Significant Predictor of Treatment Failure after High-Intensity Focussed Ultrasound (HIFU) Treatment of Localised Prostate CancerEuropean Urology200867
50Analysis of Sex Differences in Cancer-Specific Survival and Perioperative Mortality Following Radical Cystectomy: Results of a Large German Multicenter Study of Nearly 2500 Patients with Urothelial Carcinoma of the BladderGender Medicine201265